Bridging the gap in type 2 diabetes care – Overcoming therapeutic inertia and optimising the use of second generation basal insulins in chronic kidney disease
Novel insulin formulations and second-generation basal insulin therapy become essential components of best-practice glycaemic therapy
Learning objectives
You will learn:
- How early and individualised treatment intensification improves glycaemic control and prevents diabetes complications
- How to tailor pharmacological therapy in type 2 diabetes according to comorbidities
- When and how to initiate basal insulin therapy and combination therapy
- What real-world evidence from key studies reveals about the safety and efficacy of basal insulins in type 2 diabetes and chronic kidney disease.
To access this module, please register or login:
